BenjaminManningMDPhD

Head & Neck Cancer, Melanoma, Thoracic Cancer

Assistant Professor of Medicine

Dr. Manning is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
420 Delaware St SE
MMC 480
Minneapolis, MN 55455
Phone+1 612-626-2446

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2020
University of Pennsylvania Health SystemResidency, Internal Medicine, 2017 - 2020
University of Minnesota Medical SchoolClass of 2017

PubMed

75 citations
Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
Brian Ball, Christopher Famulare, Eytan M. Stein, Martin S. Tallman, Andriy Derkach
Blood Advances. 2020-07-14
23 citations
Neuropeptide-Induced Mast Cell Degranulation and Characterization of Signaling Modulation in Response to IgE Conditioning.
Benjamin M. Manning, Sarah M. Gruba, A. Meyer, Christy L. Haynes
ACS Chemical Biology. 2016-09-26
10 citations
Single-cell analysis of mast cell degranulation induced by airway smooth muscle-secreted chemokines.
Benjamin M. Manning, A. Meyer, Sarah M. Gruba, Christy L. Haynes
Biochimica Et Biophysica Acta. 2015-09-01

Abstracts/Posters

Combined Venetoclax and Hypomethylating Agent (HMA) Therapy Induces High Response Rates in Patients with Myelodysplastic Syndrome Including Patients Previously Failing...
Benjamin M Manning, 61st Annual American Society of Hematology Meeting, San Diego, CA, 12/9/2019